US Map / Texas
State TX

Clinical Trials in Texas

Texas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Texas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 733 actively recruiting studies with Texas sites out of 733 registered in total. The busiest research areas in Texas are Colorectal Cancer, Ovarian Cancer, Advanced Solid Tumor. Leading sponsors running trials in the state include M.D. Anderson Cancer Center, University of Texas Southwestern Medical Center, The University of Texas Health Science Center, Houston. By stage, Texas trials break down as Phase 1 (194), Phase 2 (218), Phase 3 (133), Phase 4 (23).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
733
Recruiting Now
733
← Back to US Map
Top Conditions in Texas
Colorectal Cancer (16)Ovarian Cancer (15)Advanced Solid Tumor (15)Prostate Cancer (14)Advanced Solid Tumors (12)Solid Tumor (11)Breast Cancer (11)Cancer (10)Heart Failure (9)Acute Myeloid Leukemia (9)Schizophrenia (9)Obesity (9)

Frequently Asked Questions — Clinical Trials in Texas

How many clinical trials are currently recruiting in Texas?
ClinicalMetric currently tracks 733 actively recruiting clinical trials with at least one location in Texas. The total number of registered studies—including active but not currently enrolling trials—is 733. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Texas?
Texas hosts clinical trials across a broad range of medical conditions, including Colorectal Cancer, Ovarian Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Texas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Texas?
To join a clinical trial in Texas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Texas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Texas

NCT04398628 N/A
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Condition
Hematologic Disorder
Enrollment
3,000 pts
Location
United States
Sponsor
American Thrombosis and Hemost
View Trial →
NCT06303505 Phase 1, Phase 2
Recruiting
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Pa...
Condition
Ovarian Cancer
Enrollment
334 pts
Location
United States, Belgium, Germany
Sponsor
Gilead Sciences
View Trial →
NCT04604522 N/A
Recruiting
Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis...
Condition
Bronchiolitis Obliterans
Enrollment
15 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT05355051 Phase 2
Recruiting
A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patient...
Condition
Hodgkin's Lymphoma
Enrollment
24 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT06022029 Phase 1
Recruiting
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in ...
Condition
Triple Negative Breast Cancer
Enrollment
168 pts
Location
United States, Australia
Sponsor
OncoNano Medicine, Inc.
View Trial →
NCT07186101 Phase 2
Recruiting
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately ...
Condition
Ulcerative Colitis
Enrollment
252 pts
Location
United States, Austria, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT07280702 Phase 4
Recruiting
Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Dise...
Condition
Psoriatic Arthritis (PsA)
Enrollment
128 pts
Location
United States
Sponsor
University of Texas Southweste
View Trial →
NCT07204275 Phase 2, Phase 3
Recruiting
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants...
Condition
Primary Membranous Nephropathy
Enrollment
176 pts
Location
United States, Australia, Brazil
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT00477100 N/A
Recruiting
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Ti...
Condition
Inflammatory Breast Carcinoma
Enrollment
1,200 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07007312 Phase 3
Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With...
Condition
Acute Myeloid Leukemia (AML)
Enrollment
1,300 pts
Location
United States, Australia, Belgium
Sponsor
Kura Oncology, Inc.
View Trial →
NCT04595422 N/A
Recruiting
Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines
Condition
Lung Carcinoma
Enrollment
800 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07196839 N/A
Recruiting
Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyl...
Condition
Transthyretin (TTR) Amyloid Cardiomyopathy
Enrollment
50 pts
Location
United States
Sponsor
University of Texas Southweste
View Trial →
NCT04789681 Phase 2
Recruiting
Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
Condition
Lung Carcinoma
Enrollment
50 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07085767 Phase 3
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/...
Condition
Breast Cancer
Enrollment
1,000 pts
Location
United States, Australia, Austria
Sponsor
Olema Pharmaceuticals, Inc.
View Trial →
NCT06983041 N/A
Recruiting
Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Can...
Condition
Vulvovaginal Candidiasis (VVC)
Enrollment
55 pts
Location
United States
Sponsor
Coologics, Inc
View Trial →
NCT07462377 Phase 1
Recruiting
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Condition
Epidermal Growth Factor
Enrollment
110 pts
Location
United States, South Korea, Taiwan
Sponsor
EpiBiologics
View Trial →
NCT05026983 Phase 2
Recruiting
Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central...
Condition
Clinical Stage IV Cutaneous Melanoma AJCC v8
Enrollment
35 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT05421741 Phase 4
Recruiting
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
Condition
Osteomyelitis Tibia
Enrollment
242 pts
Location
United States
Sponsor
Wake Forest University Health
View Trial →
NCT07128303 Phase 1
Recruiting
Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
476 pts
Location
United States, South Korea, Spain
Sponsor
Gilead Sciences
View Trial →
NCT07246954 N/A
Recruiting
A Chaplain-clinician Led Spiritual Care (PEACE) Intervention on Spiritual/Religi...
Condition
Spiritual Care
Enrollment
60 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT06556693 N/A
Recruiting
Janus II Feasibility
Condition
Sleep Apnea
Enrollment
40 pts
Location
United States
Sponsor
Zoll Medical Corporation
View Trial →
NCT05616793 Phase 1, Phase 2
Recruiting
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retina...
Condition
LCA5
Enrollment
22 pts
Location
United States
Sponsor
Opus Genetics, Inc
View Trial →
NCT04638647 Phase 4
Recruiting
Secukinumab Open Label Roll-over Extension Protocol
Condition
Autoimmunity, Inflammation
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT05319015 Phase 2
Recruiting
Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus
Condition
Renal Cell Carcinoma
Enrollment
30 pts
Location
United States
Sponsor
University of Texas Southweste
View Trial →
NCT06558825 N/A
Recruiting
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with...
Condition
Substance Use
Enrollment
60 pts
Location
United States
Sponsor
The University of Texas Health
View Trial →
Page 5 of 30 — 733 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology